Base de dados : MEDLINE
Pesquisa : C10.597.900 [Categoria DeCS]
Referências encontradas : 6564 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 657 ir para página                         

  1 / 6564 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29376612
[Au] Autor:Kasyan GR; Sukhikh SO; Pushkar DY
[Ad] Endereço:Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia.
[Ti] Título:[The place of mirabegron in clinical practice].
[So] Source:Urologiia;(6):144-148, 2017 Dec.
[Is] ISSN:1728-2985
[Cp] País de publicação:Russia (Federation)
[La] Idioma:rus
[Ab] Resumo:Currently, a wide range of different drugs is available for te management of overactive bladder. This creates problems when it comes to drug selection and personalized care for each patient. Mirabegron is the only 3-adrenomimetic agent for the treatment of urinary disorders, which, after careful long-term multi-center randomized trials, has been approved for use in Europe and North America. Mirabegron has proven to be very effective in patients who had previously received anticholinergic drugs and discontinued them because of the insufficient therapeutic effect or pronounced adverse reactions. However, the question of using Mirabegron as a first-line treatment for overactive bladder and the existing limitations in its administration in clinical urology practice remains open.
[Mh] Termos MeSH primário: Acetanilidas/efeitos adversos
Acetanilidas/uso terapêutico
Tiazóis/efeitos adversos
Tiazóis/uso terapêutico
Bexiga Urinaria Neurogênica/tratamento farmacológico
Incontinência Urinária/tratamento farmacológico
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
Masculino
Bexiga Urinaria Neurogênica/fisiopatologia
Incontinência Urinária/fisiopatologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Acetanilides); 0 (Thiazoles); MVR3JL3B2V (mirabegron)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180309
[Lr] Data última revisão:
180309
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180130
[St] Status:MEDLINE


  2 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27775158
[Au] Autor:Faleiros F; Pelosi G; Warschausky S; Tate D; Käppler C; Thomas E
[Ti] Título:Factors Influencing the Use of Intermittent Bladder Catheterization by Individuals With Spina Bifida in Brazil and Germany.
[So] Source:Rehabil Nurs;43(1):46-51, 2018 Jan/Feb.
[Is] ISSN:2048-7940
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: Intermittent catheterization (IC) often is essential for individuals with spina bifida/myelomeningocele (SBM) and neurogenic bladder. This study aimed to identify and analyze the factors that influence the use of IC. DESIGN AND METHODS: Descriptive study with convenience sampling. Data were collected using printed (Brazil) and online (Germany) questionnaires, and analyzed using multivariate logistical regression and analysis of variance. The study included 100 Brazilian and 100 German patients, aged 0-55 years, with SBM who utilized IC. FINDINGS: Intermittent catheterization was used by 188 of the 200 patients. Three variables were important for predicting who did or did not use IC: no discontinuation of IC, absence of technical difficulty, and daily frequency of IC. CONCLUSIONS AND CLINICAL RELEVANCE: Findings suggest that difficulties with IC use experienced by spina bifida patients and their family members that predicted full discontinuation tended to be personal variables, rather than demographic or medical characteristics.
[Mh] Termos MeSH primário: Cateterismo Uretral Intermitente/utilização
Disrafismo Espinal/terapia
[Mh] Termos MeSH secundário: Adolescente
Adulto
Brasil
Criança
Pré-Escolar
Feminino
Alemanha
Seres Humanos
Lactente
Cateterismo Uretral Intermitente/psicologia
Modelos Logísticos
Masculino
Meia-Idade
Enfermagem em Reabilitação/métodos
Disrafismo Espinal/enfermagem
Disrafismo Espinal/psicologia
Inquéritos e Questionários
Bexiga Urinaria Neurogênica/enfermagem
Bexiga Urinaria Neurogênica/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180226
[Lr] Data última revisão:
180226
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE
[do] DOI:10.1002/rnj.302


  3 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29202586
[Au] Autor:Ladi-Seyedian SS; Nabavizadeh B; Sharifi-Rad L; Kajbafzadeh AM
[Ad] Endereço:a Pediatric Urology and Regenerative Medicine Research Center, Children's Medical Center , Tehran University of Medical Sciences , Tehran , Iran.
[Ti] Título:Pharmacological treatments available for the management of underactive bladder in neurological conditions.
[So] Source:Expert Rev Clin Pharmacol;11(2):193-204, 2018 Feb.
[Is] ISSN:1751-2441
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Underactive bladder (UAB) is a common cause of lower urinary tract dysfunction which has an increasing incidence with aging. It is characterized as an incompetent detrusor contraction with reduced strength and/or duration to completely empty the bladder. UAB is observed in both men and women. The exact definition, classification, and pathophysiological mechanism responsible for UAB is still debatable, however neurologic, myogenic, and iatrogenic causes are explained. The symptom complex related to UAB includes hesitancy, diminished sensation of bladder filling, a slow urinary stream, increased post-void residue, and etc. Areas covered: We reviewed the current understanding of UAB with special focus on pharmacological treatments and potential pharmacotherapy options particularly in neurological conditions. Also, the definition, etiology, symptoms, diagnosis and management of UAB were discussed in this review. Expert commentary: The underlying mechanism of UAB is not clear yet. Therefore; the lack of efficient pharmacotherapies is evident in such patients. Prior to any decision for pharmacological or surgical interventions, the underlying causes of UAB and detrusor impairment in each patient should be distinguished. Future researches need to address the exact dynamics of detrusor contraction and the muscular and neurological contributors to UAB.
[Mh] Termos MeSH primário: Sintomas do Trato Urinário Inferior/tratamento farmacológico
Doenças da Bexiga Urinária/tratamento farmacológico
Bexiga Urinaria Neurogênica/tratamento farmacológico
[Mh] Termos MeSH secundário: Fatores Etários
Envelhecimento
Animais
Feminino
Seres Humanos
Incidência
Sintomas do Trato Urinário Inferior/diagnóstico
Sintomas do Trato Urinário Inferior/fisiopatologia
Masculino
Fatores de Risco
Doenças da Bexiga Urinária/diagnóstico
Doenças da Bexiga Urinária/fisiopatologia
Bexiga Urinaria Neurogênica/diagnóstico
Bexiga Urinaria Neurogênica/fisiopatologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180222
[Lr] Data última revisão:
180222
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171206
[St] Status:MEDLINE
[do] DOI:10.1080/17512433.2018.1411801


  4 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29240338
[Ti] Título:Healthcare Costs Associated with Hydrophilic-Coated And Non-Coated Urinary Catheters for Intermittent Use In the United States.
[So] Source:Urol Nurs;36(5):233-42, 2016 Sep-Oct.
[Is] ISSN:1053-816X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This health economic evaluation simulated a cohort to compare hydrophilic-coated to non-coated catheters for intermittent catheterization. By using a Markov model, lifetime costs and catheter-related complications were investigated. Results determined that the use of hydrophilic-coated catheters save money and reduce treatment-related complications.
[Mh] Termos MeSH primário: Bacteriemia/epidemiologia
Infecções Relacionadas a Cateter/epidemiologia
Epididimite/epidemiologia
Custos de Cuidados de Saúde
Estreitamento Uretral/epidemiologia
Cálculos da Bexiga Urinária/epidemiologia
Bexiga Urinaria Neurogênica/enfermagem
Cateterismo Urinário/métodos
Cateteres Urinários/economia
Infecções Urinárias/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Idoso
Bacteriemia/economia
Infecções Relacionadas a Cateter/economia
Estudos de Coortes
Epididimite/economia
Feminino
Seres Humanos
Masculino
Cadeias de Markov
Meia-Idade
Modelos Econômicos
Autocuidado
Estados Unidos
Estreitamento Uretral/economia
Cálculos da Bexiga Urinária/economia
Cateterismo Urinário/instrumentação
Infecções Urinárias/economia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:171215
[St] Status:MEDLINE


  5 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716329
[Au] Autor:Myers JB; Patel DP; Elliott SP; Stoffel JT; Welk B; Jha A; Lenherr SM; Neurogenic Bladder Research Group
[Ad] Endereço:Genitourinary Injury and Reconstructive Urology, Department of Surgery, University of Utah, Salt Lake City, UT, USA. Electronic address: Jeremy.myers@hsc.utah.edu.
[Ti] Título:Mending Gaps in Knowledge: Collaborations in Neurogenic Bladder Research.
[So] Source:Urol Clin North Am;44(3):507-515, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Patient-reported outcomes and quality of life assessments are essential to studying conditions such as neurogenic bladder in which multiple management strategies are approximately equally efficacious. Innovations for the treatment of neurogenic bladder need to be guided by both clinical and patient-reported outcomes that are rigorously tested via high-quality prospective cohort or randomized studies. Collaborative research groups in reconstructive urology are critical to the study of uncommon disease processes because they allow studies to be powered adequately, foster innovative treatment strategies through collaboration, and help moderate the risk of investigator and or institutional biases.
[Mh] Termos MeSH primário: Pesquisa Biomédica
Bexiga Urinaria Neurogênica
[Mh] Termos MeSH secundário: Seres Humanos
Medidas de Resultados Relatados pelo Paciente
Estados Unidos
Bexiga Urinaria Neurogênica/etiologia
Bexiga Urinaria Neurogênica/cirurgia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  6 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716327
[Au] Autor:Gor RA; Elliott SP
[Ad] Endereço:Department of Urology, University of Minnesota, 420 Delaware Street Southeast, MMC 394, Minneapolis, MN 55455, USA.
[Ti] Título:Surgical Management of Neurogenic Lower Urinary Tract Dysfunction.
[So] Source:Urol Clin North Am;44(3):475-490, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Surgery for patients with neurogenic urinary tract dysfunction (nLUTD) is indicated when medical therapy fails, to correct conditions affecting patient safety, or when surgery can enhance the quality of life better than nonoperative management. Examples include failure of maximal medical therapy, inability to perform or aversion to clean intermittent catheterization, refractory incontinence, and complications from chronic, indwelling catheters. Adults with nLUTD have competing risk factors, including previous operations, obesity, poor nutritional status, complex living arrangements, impaired dexterity/paralysis, and impaired executive and cognitive function. Complications are common in this subgroup of patients requiring enduring commitments from surgeons, patients, and their caretakers.
[Mh] Termos MeSH primário: Sintomas do Trato Urinário Inferior/cirurgia
Bexiga Urinaria Neurogênica/cirurgia
[Mh] Termos MeSH secundário: Seres Humanos
Procedimentos Cirúrgicos Urológicos/métodos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  7 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716325
[Au] Autor:Barboglio Romo PG; Gupta P
[Ad] Endereço:Female Pelvic Medicine and Reconstructive Surgery, Department of Urology, University of Michigan, 1500 East Medical Center Drive, 3875 Taubman Center, Ann Arbor, MI 48109-5330, USA.
[Ti] Título:Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction.
[So] Source:Urol Clin North Am;44(3):453-461, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Sacral and peripheral neuromodulation are minimally invasive surgical procedures that are third-line therapy options for the treatment of patients with idiopathic overactive bladder syndrome. There has been interest in their efficacy in the management of neurogenic lower urinary tract dysfunction (NLUTD). Contemporary data suggest promising outcomes for urinary and bowel symptoms in carefully selected patients with spinal cord injury and/or multiple sclerosis. This article reviews the current literature regarding urinary and bowel outcomes in patients with NLUTD and also discusses contemporary studies that suggest that treatment during particular stages of neurologic injury may prevent long-term urinary sequelae.
[Mh] Termos MeSH primário: Neuroestimuladores Implantáveis
Sintomas do Trato Urinário Inferior/cirurgia
Bexiga Urinaria Neurogênica/cirurgia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Sintomas do Trato Urinário Inferior/etiologia
Plexo Lombossacral
Esclerose Múltipla/complicações
Procedimentos Neurocirúrgicos
Sistema Nervoso Periférico
Traumatismos da Medula Espinal/complicações
Bexiga Urinaria Neurogênica/etiologia
Procedimentos Cirúrgicos Urológicos/métodos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  8 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716324
[Au] Autor:Dray EV; Cameron AP
[Ad] Endereço:Urology, University of Michigan, 1500 East, Medical Center Drive, Ann Arbor, MI 48109, USA.
[Ti] Título:Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure.
[So] Source:Urol Clin North Am;44(3):441-452, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:More than 12,000 spinal cord injuries occur annually in the United States; more than 80% of these individuals will experience urinary tract dysfunction. Despite the clinical demand, there is a paucity of guidelines for the care of these patients. Although most urologists are familiar with dangerous urodynamic parameters and the benefits of clean intermittent catheterization, these patients face a myriad of risks that may go unrecognized. In this article, the authors discuss the impact of specific neurologic diseases on the urinary tract, examine the risks inherent to each, and determine strategies for screening, prevention, and treatment of these complications.
[Mh] Termos MeSH primário: Bexiga Urinaria Neurogênica/diagnóstico
[Mh] Termos MeSH secundário: Seres Humanos
Neoplasias da Bexiga Urinária/etiologia
Bexiga Urinaria Neurogênica/complicações
Bexiga Urinaria Neurogênica/fisiopatologia
Infecções Urinárias/etiologia
Urodinâmica
Urolitíase/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  9 / 6564 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716318
[Au] Autor:Vince RA; Klausner AP
[Ad] Endereço:Division of Urology, Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
[Ti] Título:Surveillance Strategies for Neurogenic Lower Urinary Tract Dysfunction.
[So] Source:Urol Clin North Am;44(3):367-375, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Patients with neurogenic lower urinary tract dysfunction (NLUTD) experience significant morbidity and mortality due to urological complications including upper tract damage and bladder malignancy. This has led to increased surveillance in patients NLUTD. This article discusses the methods available for surveillance of patients with NLUTD and pulls information from the largest and most established organizations that have produced evidence-based surveillance guidelines for NLUTD. These organizations include the Paralyzed Veterans of America (PVA), US Department of Veterans Affairs, European Association of Urology (EAU), The NICE organization from the UK, and cites additional literature not been included in these documents.
[Mh] Termos MeSH primário: Vigilância da População
Bexiga Urinaria Neurogênica
[Mh] Termos MeSH secundário: Cistoscopia
Seres Humanos
Sintomas do Trato Urinário Inferior/diagnóstico
Sintomas do Trato Urinário Inferior/etiologia
Guias de Prática Clínica como Assunto
Bexiga Urinaria Neurogênica/complicações
Bexiga Urinaria Neurogênica/diagnóstico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  10 / 6564 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716319
[Au] Autor:Agrawal S; Agrawal RR; Wood HM
[Ad] Endereço:Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106, USA. Electronic address: shree.agrawal@case.edu.
[Ti] Título:Establishing a Multidisciplinary Approach to the Management of Neurologic Disease Affecting the Urinary Tract.
[So] Source:Urol Clin North Am;44(3):377-389, 2017 Aug.
[Is] ISSN:1558-318X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Neurologic diseases often affect the urinary tract and may be congential or acquired. The progressive nature of many neurologic diseases necessitates routine surveillance and treatment with a multidisciplinary approach. Urologic treatments may interact with pharmacologic or procedural interventions planned by other specialists, mandating close coordination of care and communication among providers. Primary care and nursing often can serve as the quarterbacks of the multidisciplinary team by identifying when a slowly progressive condition warrants further investigation and management by specialists.
[Mh] Termos MeSH primário: Equipe de Assistência ao Paciente
Bexiga Urinaria Neurogênica/terapia
Doenças Urológicas/terapia
[Mh] Termos MeSH secundário: Seres Humanos
Equipe de Assistência ao Paciente/organização & administração
Guias de Prática Clínica como Assunto
Bexiga Urinaria Neurogênica/complicações
Doenças Urológicas/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE



página 1 de 657 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde